Used primarily as a research tool in biochemical and cellular studies, this compound acts as a selective inhibitor of necroptosis, a form of programmed cell death. It helps scientists investigate the pathways involved in necrotic cell death, particularly in models of ischemic injury, neurodegenerative diseases, and inflammatory conditions. By blocking key enzymes in the necroptosis cascade, it allows researchers to distinguish between apoptosis and necroptosis in cell death mechanisms. Commonly applied in studies of stroke, organ damage, and autoimmune disorders to assess the therapeutic potential of inhibiting necrotic pathways. Also used in combination with other cell death inhibitors to study overlapping cell death mechanisms.